• News

"How Mount Sinai Health System Fosters Collaboration To Fight Cancer" - Joel Dudley, PhD and Samir Parekh, PhD

  • Harvard Business Review
  • New York, NY
  • (October 02, 2018)

Precision cancer medicine — sequencing a patient’s DNA in order to customize cancer treatments — shows promise, but is very much in its infancy. It’s still not nearly precise enough to launch a winning battle against many forms of cancer. To dramatically advance in this field, clinicians, medical researchers, and computer scientists must substantially deepen their collaboration. The Mount Sinai Health System is organized differently from most, as one integrated institution. Doctors from the seven Mount Sinai hospitals work side by side with researchers from the Icahn School of Medicine at Mount Sinai. Indeed, many clinicians also have Sinai research labs. If a clinician and a researcher devise a viable idea to solve a medical problem, they are free to join forces and pursue the project. This makes it possible to rapidly bring a finding from the lab bench to the patient bedside.

- Joel Dudley, PhD, Director, Institute for Next Generation Healthcare, Associate Professor, Genetics and Genomic Sciences, Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, Executive Vice President, Precision Health, Mount Sinai Health System

- Samir Parekh, MBBS, Associate Professor, Oncological Sciences, Medicine, Hematology and Medical Oncology, Director, Translational Research in Myeloma, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

Learn more